文献速递角膜与眼表疾病

虹膜角膜内皮综合征中穿透性角膜移植与板层内皮角膜移植的结局:系统综述与Meta分析

Outcomes of Penetrating Keratoplasty Versus Lamellar Endothelial Keratoplasty in Iridocorneal Endothelial Syndrome: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Ophthalmol · 2025-04-19

本系统综述与个体患者数据Meta分析纳入19项研究,比较穿透性角膜移植(PK)、Descemet剥离内皮角膜移植(DSEK)与Descemet膜内皮角膜移植(DMEK)在虹膜角膜内皮(ICE)综合征患者中的结局。基于至少10例研究的个体患者数据,PK的移植物存活优于DSEK;三种手术的最佳矫正视力(BSCVA)改善无显著差异,DSEK与DMEK术后6个月和12个月的内皮细胞密度(ECD)无显著差异。作者结论认为PK移植物存活优于DSEK,但需进一步研究和更多证据才能得出更确定的结论。

要点

  • 基于至少10例研究的个体患者数据,ICE综合征患者PK的移植物存活优于DSEK。
  • PK、DSEK与DMEK的BSCVA改善无显著差异(P = .92)。
  • 有无青光眼或白内障手术史的患者移植物存活无显著差异。

核心结论

  • 在ICE综合征患者中,PK的移植物存活优于DSEK。
  • PK、DSEK和DMEK的BSCVA改善相当。
  • 青光眼手术无论发生在角膜移植前还是后,似乎对移植物存活无显著影响。
  • 作者指出需进一步研究和更多证据才能得出更确定的结论。

研究设计与样本

  • 系统综述与个体患者数据(IPD)Meta分析,于PROSPERO预注册(注册号CRD42024539444)。
  • 检索Embase、MEDLINE(通过PubMed)和Cochrane对照试验中心注册库(CENTRAL),截止2024年4月24日。
  • 从1963项筛选研究中纳入19项报告PK、DSEK或DMEK后临床结局的研究。
  • 按Cochrane手册进行数据提取与合成,采用ROBINS-I和Joanna Briggs研究所批判性评价清单评估偏倚风险。
  • 采用随机效应模型进行Meta分析,用Q检验和I2统计量评估研究间异质性。

主要发现

  • 基于至少10例研究的个体患者数据,多变量合并Kaplan-Meier曲线(95%CI)显示ICE综合征患者PK的移植物存活优于DSEK。
  • BSCVA改善在PK [-0.77(95%CI,-1.45至-0.09)]、DSEK [-0.87(95%CI,-1.35至-0.39)]和DMEK [-0.85(95%CI,-1.07至-0.62)]之间无显著差异(P = .92)。
  • DSEK与DMEK术后6个月(P = .88)和12个月(P = .33)的ECD无显著差异。
  • 个体患者数据分析显示,有无 anytime 青光眼(-0.04 ± 0.50 SEM;P = .940)或白内障手术(-0.45 ± 0.40 SEM;P = .265)的患者移植物存活无显著差异。

关键数值与推荐

  • PK组BSCVA变化为-0.77(95%CI,-1.45至-0.09),DSEK组为-0.87(95%CI,-1.35至-0.39),DMEK组为-0.85(95%CI,-1.07至-0.62)。
  • BSCVA改善在PK、DSEK与DMEK之间比较的P = .92。
  • DSEK与DMEK术后6个月ECD比较的P = .88,术后12个月比较的P = .33。
  • 有无 anytime 青光眼者移植物存活比较为-0.04 ± 0.50 SEM(P = .940);有无白内障手术者比较为-0.45 ± 0.40 SEM(P = .265)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步研究和更多证据才能得出更确定的结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare surgical outcomes following penetrating keratoplasty (PK), Descemet stripping endothelial keratoplasty (DSEK), and Descemet membrane endothelial keratoplasty (DMEK) in patients with iridocorneal endothelial (ICE) syndrome. DESIGN: Systematic review and meta-analysis on individual patient data (IPD). METHODS: Pre-registration was performed in the PROSPERO database (registration number: CRD42024539444). Eligible studies from Embase, MEDLINE (via PubMed), and the Cochrane Central Register of Controlled Trials (CENTRAL) were retrieved up to April 24, 2024. Studies were included those reporting clinical outcomes after PK, DSEK, or DMEK- graft survival, best spectacle-corrected visual acuity (BSCVA) and endothelial cell density (ECD) - in people with ICE syndrome. Cochrane Handbook was followed for data extraction/ synthesis, and the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) and the Joanna Briggs Institute Critical Appraisal Checklists were used to assess risk of bias. Meta-analyses were conducted using a random-effects model. Heterogeneity between studies was assessed using Q-test and I2 statistics. RESULTS: Nineteen of the 1963 screened studies were included in the meta-analysis. Multivariate pooled Kaplan-Meier curves with 95% confidence intervals, based on IPD from studies with at least 10 cases indicated that graft survival was better after PK compared to DSEK in patients with ICE syndrome. No significant difference (P = .92) was found in BSCVA improvement between PK [-0.77 (95% CI, -1.45 to -0.09)], DSEK [-0.87 (95% CI, -1.35 to -0.39)] and DMEK [-0.85 (95% CI, -1.07 to -0.62)]. No significant differences in ECD were observed between DSEK and DMEK 6 (P = .88) and 12 months (P = .33) postoperatively. IPD analysis revealed no significant difference in graft survival between patients with and without anytime glaucoma (-0.04 ± 0.50 SEM; P = .940) or cataract surgery (-0.45 ± 0.40 SEM; P = .265). CONCLUSIONS: PK demonstrated better graft survival compared to DSEK in patients with ICE, however, further research and additional evidence are needed to draw more definitive conclusions. Improvements in BSCVA were comparable across PK, DSEK and DMEK. Glaucoma surgery, whether performed before or after keratoplasty, appear to have no significant impact on graft survival.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Tóth G, Váncsa S, Kói T, et al. Outcomes of Penetrating Keratoplasty Versus Lamellar Endothelial Keratoplasty in Iridocorneal Endothelial Syndrome: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2025. PMID: 40258484. doi:10.1016/j.ajo.2025.04.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。